4 insiders reported 7 Form 4 transactions for Adaptimmune Therapeutics PLC (ADAP) over the past 18 months (most recent 2025-09-03). Recent activity: Wood Gavin (Chief Financial Officer) Sell 96,000 shares, Bertrand William C JR (Chief Operating Officer) Sell 207,000 shares, Behbahani Ali (Director) Sell 4.8M shares, Behbahani Ali (Director) Sell 14.7M shares, EcoR1 Capital, LLC (Insider) Sell 33.9M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-03 | Wood Gavin | Chief Financial Officer | Sell | 96,000 | $960 |
| 2025-08-29 | Bertrand William C JR | Chief Operating Officer | Sell | 207,000 | $2,070 |
| 2025-08-19 | Behbahani Ali | Director | Sell | 4.8M | $48,282 |
| 2025-08-19 | Behbahani Ali | Director | Sell | 14.7M | $146,718 |
| 2025-07-30 | EcoR1 Capital, LLC | Insider | Sell | 33.9M | $3.7M |
| 2025-07-30 | EcoR1 Capital, LLC | Insider | Sell | 2.7M | $268,746 |
| 2025-07-30 | EcoR1 Capital, LLC | Insider | Sell | 27.4M | $2.7M |
Source: SEC Form 4 filings · as of 2025-09-03